237 related articles for article (PubMed ID: 33683811)
1. Characteristics and outcome-related factors of seizure at the first onset of autoimmune encephalitis: A retrospective study.
Wang Y; Li X; He P; Yin J; Dong R; Fu Y; Zhang H
CNS Neurosci Ther; 2021 Jun; 27(6):694-701. PubMed ID: 33683811
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and long-term outcomes of seizures associated with autoimmune encephalitis: A follow-up study in East China.
Yao L; Yue W; Xunyi W; Jianhong W; Guoxing Z; Zhen H
J Clin Neurosci; 2019 Oct; 68():73-79. PubMed ID: 31331752
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
4. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
Front Neurol; 2018; 9():1136. PubMed ID: 30671012
[TBL] [Abstract][Full Text] [Related]
6. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
[TBL] [Abstract][Full Text] [Related]
7. Seizures and risk of epilepsy in anti-NMDAR, anti-LGI1, and anti-GABA
Shen CH; Fang GL; Yang F; Cai MT; Zheng Y; Fang W; Guo Y; Zhang YX; Ding MP
Ann Clin Transl Neurol; 2020 Aug; 7(8):1392-1399. PubMed ID: 32710704
[TBL] [Abstract][Full Text] [Related]
8. Long-term seizure outcome in patients with status epilepticus due to acute encephalitis.
Leng X; Yuan F; Zhao J; Song C; Zhao Z; Zhang Y; Gao Q; Yang F; Jiang W
Seizure; 2019 Jul; 69():70-75. PubMed ID: 30981052
[TBL] [Abstract][Full Text] [Related]
9. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
10. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
[TBL] [Abstract][Full Text] [Related]
11. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
Caputo D; Iorio R; Vigevano F; Fusco L
Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
[TBL] [Abstract][Full Text] [Related]
12. Effect of Antiepileptic Drugs for Acute and Chronic Seizures in Children with Encephalitis.
Lin KL; Lin JJ; Hsia SH; Chou ML; Hung PC; Wang HS;
PLoS One; 2015; 10(10):e0139974. PubMed ID: 26444013
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
14. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody-associated encephalitis in childhood: Clinical and etiologic risk factors.
Pillai SC; Mohammad SS; Hacohen Y; Tantsis E; Prelog K; Barnes EH; Gill D; Lim MJ; Brilot F; Vincent A; Dale RC
Epilepsia; 2016 Jan; 57(1):e7-e11. PubMed ID: 26592968
[TBL] [Abstract][Full Text] [Related]
15. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies.
Petit-Pedrol M; Armangue T; Peng X; Bataller L; Cellucci T; Davis R; McCracken L; Martinez-Hernandez E; Mason WP; Kruer MC; Ritacco DG; Grisold W; Meaney BF; Alcalá C; Sillevis-Smitt P; Titulaer MJ; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2014 Mar; 13(3):276-86. PubMed ID: 24462240
[TBL] [Abstract][Full Text] [Related]
16. Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis.
Ilyas-Feldmann M; Prüß H; Holtkamp M
Seizure; 2021 Mar; 86():138-143. PubMed ID: 33618141
[TBL] [Abstract][Full Text] [Related]
17. Clinical Character of CASPR2 Autoimmune Encephalitis: A Multiple Center Retrospective Study.
Qin X; Yang H; Zhu F; Wang Q; Shan W
Front Immunol; 2021; 12():652864. PubMed ID: 34054814
[TBL] [Abstract][Full Text] [Related]
18. Determinants for Control of Status Epilepticus in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Yen HK; Tang SC; Tsai LK; Fan SP; Yeh SJ; Jeng JS
Acta Neurol Taiwan; 2021 Mar; 30(1)():1-10. PubMed ID: 34549395
[TBL] [Abstract][Full Text] [Related]
19. Electroclinical features of seizures associated with autoimmune encephalitis.
Steriade C; Moosa ANV; Hantus S; Prayson RA; Alexopoulos A; Rae-Grant A
Seizure; 2018 Aug; 60():198-204. PubMed ID: 30031297
[TBL] [Abstract][Full Text] [Related]
20. Long-term seizure outcomes in patients with autoimmune encephalitis: A prospective observational registry study update.
Liu X; Guo K; Lin J; Gong X; Li A; Zhou D; Hong Z
Epilepsia; 2022 Jul; 63(7):1812-1821. PubMed ID: 35357695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
